Finance

Lists
Why is NSB down 7.14%?
Dive Deeper
NSB:ASX
Neuroscientific Biopharmaceuticals Ltd
A$0.052
-7.14%
(-0.0040) 1D
Oct 26, 4:11:40 PM GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for NSB...
Open
A$0.06
High
A$0.06
Low
A$0.04
Mkt. cap
18.91M
Avg. vol.
102.12K
Volume
500.63K
52-wk high
A$0.18
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
389.72M
Open
A$0.06
High
A$0.06
Low
A$0.04
Mkt. cap
18.91M
Avg. vol.
102.12K
Volume
500.63K
52-wk high
A$0.18
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
389.72M
News stories
From web sources and news partners
About Neuroscientific Biopharmaceuticals Ltd
CEO-
Employees-
Founded2002
Headquarters-
SectorBiotechnology
Websiteneuroscientific.com
Last report
Jul 27, 2026
Fiscal period
Q4 2026
- / -
Revenue / Est. (AUD)
42.38K / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
158.95K
158.95K
42.38K
42.38K
Cost of goods sold
23.53K
23.53K
48.66K
48.66K
Cost of revenue
23.53K
23.53K
48.66K
48.66K
Research and development expenses
225.61K
225.61K
316.20K
316.20K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
409.06K
409.06K
628.30K
628.30K
Operating expense
1.04M
1.04M
1.44M
1.44M
Total operating expenses
1.07M
1.07M
1.49M
1.49M
Operating income
-908.64K
-908.64K
-1.44M
-1.44M
Other non operating income
-
-
-
-
EBT including unusual items
-849.71K
-849.71K
-1.50M
-1.50M
EBT excluding unusual items
-849.71K
-849.71K
-1.39M
-1.39M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-849.71K
-849.71K
-1.50M
-1.50M
Net profit margin
-534.56%
-534.56%
-3,532.28%
-3,532.28%
Earnings per share
-
-
-
-
Interest and investment income
59.20K
59.20K
54.17K
54.17K
Interest expense
-263.00
-263.00
-1.57K
-1.57K
Net interest expenses
58.94K
58.94K
52.60K
52.60K
Depreciation and amortization charges
383.00
383.00
6.24K
6.24K
EBITDA
-597.26K
-597.26K
-1.06M
-1.06M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps